Menu Search
Equities

Merck & Co Inc

MRKCL:SGO

Merck & Co Inc

Actions
  • Price (CLP)100,000.00
  • Today's Change530.00 / 0.53%
  • Shares traded19.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 11 2024 12:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Merck & Co Inc's net income fell -97.49% from 14.52bn to 365.00m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 16.78% to 17.27%.
Gross margin76.59%
Net profit margin19.25%
Operating margin21.60%
Return on assets10.85%
Return on equity28.33%
Return on investment14.19%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Merck & Co Inc fell by 5.86bn. However, the company earned 13.01bn from its operations for a Cash Flow Margin of 21.64%. In addition the company used 14.08bn on investing activities and also paid 4.81bn in financing cash flows.
Cash flow per share6.49
Price/Cash flow per share15.27
Book value per share17.58
Tangible book value per share2.29
More ▼

Balance sheet in USDView more

Merck & Co Inc has a Debt to Total Capital ratio of 46.11%, a lower figure than the previous year's 82.36%.
Current ratio1.36
Quick ratio1.15
Total debt/total equity0.8568
Total debt/total capital0.4611
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)2.85%
Div growth rate (5 year)8.26%
Payout ratio (TTM)64.59%
EPS growth(5 years)-43.23
EPS (TTM) vs
TTM 1 year ago		164.22
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.